Clinical Trial

The Effect of Melatonin Supplementation on Cumulus Cells and IVF Outcomes

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 13, 2024 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study investigates the effects of melatonin supplementation on cumulus cell gene expression and in vitro fertilization (IVF) outcomes in women over 35 years old. In the study group, patients will receive melatonin supplementation for at least two months prior to their IVF cycles. Cumulus cells will be collected after oocyte retrieval, and IVF outcomes will be assessed.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-08.
Trial Details
NCT Number NCT06546774
Lead Sponsor Kaohsiung Veterans General Hospital.
Conditions Unrecognized Condition
Enrollment 200 participants
Start Date 2021-05-01
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-13